ValiRx - ValiSeek Clinical Development Update
VAL
Thu, 14 Jul 2016, 11:15 BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr. Susie Dilly, CEO of ValiSeek, provides an update on the clinical development of its novel cancer treatment drug, VAL401. ValiSeek confirms that it has received positive opinion and approval from the ethics committee, a significant step in the regulatory process prior to patient recruitment and dosing.
